Boothbay Fund Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-3,864
Closed -$338K – 2183
2025
Q3
$338K Buy
+3,864
New +$345K ﹤0.01% 1379

Other funds holding LMAT

Boothbay Fund Management's LMAT Position: Q4 2025 in Review

Boothbay Fund Management sold out of LeMaitre Vascular (LMAT) in Q4 2025, closing a stake of 3,864 shares — an estimated $338K sold.

Boothbay Fund Management first reported a position in LMAT in Q3 2025 and held it in 1 quarter. The position peaked at $338K in Q3 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.

  • Boothbay Fund Management reported no remaining LeMaitre Vascular position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 3,864 LeMaitre Vascular shares in Q4 2025, an estimated $338K.
  • Boothbay Fund Management first reported a position in LeMaitre Vascular in Q3 2025 and held it in 1 quarter.
  • Boothbay Fund Management's LeMaitre Vascular position peaked at $338K in Q3 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.